Bavarian AG

the Bavarian AG is an internationally active company of the chemical industry with head office in Leverkusen. The company was created 1863 and came up 1925 in the industrial union colors . 1951 were again created the enterprise. The Bavarian company has today 350Societies and 93,700 coworkers (conditions 31. December 2005). In the year 2005 those gained Bavarian AG a settled profit of 2,812 billion Euro (PUBLIC EXHIBITION FOR MULTIMEDIA) with a conversion of over 27 billion Euro.

The operational business is led by three partial companies:

• Bavarian HealthCare AG
• Bavarian CropScience AG
• Bavarian MaterialScience AG

most humans connect with the name Bavarian the most well-known medicine of the enterprise, the pain means aspirin.

Landmark of the Bavarian company is the Bavarian cross, which is to be seen at many larger locations of the enterprise. In a circle is horizontalto see and perpendicularly the signature BAVARIAN.

With the predecessor of the Bavarian cross a lion with wings supported itself by a world ball. 1930 were installed in Leverkusen the then largest Lichtreklame of the world: The diameter amounted to 72 meters, 2200 lamps provided for the lighting. The thinghung between two 126 meters high chimneys.1958 one made the Bavarian cross smaller on a diameter of 51 meters. This corresponds to the today's form (January 2004).

situation and traffic

the chemistry park Leverkusen, Hauptwerk and - seat the Bavarian AG, lies to the half in Leverkusen pointing village and on the other hand in Cologne quarters tearing pool of broadcasting corporations. It possesses one Rhine binding, as well as a good road binding with the cross Leverkusen (A1/ A3). The airport Cologne/Bonn is in the proximity, thus is ensured an air binding.

On the other Rhine side are the Ford works.

history

establishment phase

thatEnterprise became at the 1. August 1863 in Barmen - today a quarter of Wuppertal - of Friedrich Bavarian and Johann Friedrich Weskott based. Synthetic color production represented the early purpose of the enterprise. The first large work developed in Wuppertal Elberfeld, there became laterthen also a majority of the most important medicines invented like the aspirin or the Sulfonamide /Chemotherapie (Gerhard Domagk - Medizinnobelpreis 1939) up to heroin. This made Bavarian already in Wuppertal the world company. The high number of inhabitants of over 400.000 inhabitants in the highly industrialized valley thatWupper did not permit a further expansion topografisch conditionally. The Wuppertaler chemist and successor of Friedrich Bavarian, Carl Duisberg, became fündig in pointing village, a 2000-Einwohner-Städtchen on the Rhine, surrounded by field, - the birth later Leverkusen.

growth andExpansion

in the following years grew the enterprise rapidly, the number of the coworkers rose from three in the year of the foundation 1863 to 1881 on over 300 persons employed. The further expansion was made possible by the transformation of the enterprise into a corporation 1881.

English Bavarian advertisement for aspirin, heroin, Lycetol,Salophen among other things

The research was developed among other things by Carl Duisberg. In Wuppertal - Elberfeld develops a modern scientific laboratory. The enterprise around the turn of the century increased internationally actively and opens new business fields. To the color production, which had further the largest portion of the conversion, camea pharmaceutical department. 1897 were synthesized for the first time heroin. The most well-known result of the Bavarian research is that 1899 on the market medicine brought aspirin. Bavarian began 1904 with the production of photo chemicals. After the enterprise had its seat some years in Wuppertal Elberfeld, this location becamewith further growth too small.Leverkusen became 1912 new seat carrier.

1913 have the enterprise approx. 10,000 coworkers, of it nearly 1,000 abroad. The enterprise created subsidiaries in France, Great Britain, Belgium, Russia and the USA. The export took a portion to 1913of 80% at the enterprise conversion.

the enterprise a majority of its

sales prospects loses the consequences of the First World War by the First World War. In Russia the subsidiary in consequence of the Russian revolution is expropriated, seized into which the USA the firm's property including all patentsand to the competition sells. The conversion sinks from 1913 to 1919 around a third. During this time Bavarian is one of the main suppliers of poisonous gas for the front.

I.G. Dye industry

already since 1905 existed a community of interests between Bavarian, Agfa and the BASF (S. Industrial union colors). 1915 were expanded these with further enterprises of the dye industry to a large community of interests.

fusion

the German Farbstoffindustrie after the war more badly stood there there than before, decided the members of the community of interests 1925 to the fusion. The fortune thatCompany Bayer will transfer the mark Bavarian to the again created industrial union dye industry AG and from the trade register is removed.

world economic crisis

also the I.G. Dye industry AG is not exempted from the world economic crisis at the beginning of the 1930er. The occupation and production sink drastically, of12,450 coworkers in the year to 1932 2,650 will dismiss 1929. Each fifth loses its job.

the Second World War

rank the works of the operating association for the National Socialist regime in the Second World War among the “war-important “enterprises. By the war the requirements growin addition, to production, ever more coworker to the war service are drawn in. Also in the works of the operating association obligation and immigrant workers are used. The portion of these constitutes a third of the staff to its high point.

To 14. April 1945 becomes the work Leverkusen throughthe Americans taken. The works at the Niederrhein lie in the British zone, therefore the British military government has complete control of them in the following years.

allied winner powers plead

to reestablishment the Bavarian AG after the war for a breakdown of the industrial unioninto as much as possible small enterprises. Since these would be hardly lebensfähig however, the industrial union in only 12 enterprises, under it also the Bavarian AG is subdivided. The Bavarian AG became to 19. December 1951 again based.

reconstruction

after the company for the second time anyForeign asset lost, the selling as fast as possible is abroad again developed. Bavarian concentrates again on research and development and can register a positive business process in the context of the “Wirtschaftswunders “.

1962 have those Bavarian AG in the Federal Republic of 61,000 persons employed and gain annual turnoverof 4 billion DM.

oil crisis more difficult

in the time of 1973 to beginning of the 1980er years make the high prices for chemistry raw materials from oil the business of Bavarian. Bavarian develops however nevertheless its foreign selling, particularly in west Europe and the USA. By several assumptions Bavarian achieves an important position also on the US-Pharmamarkt.1974 are put the foundation-stone for the fifth Bavarian work in Germany in Brunsbüttel. The plant protection research is developed, 1979 likewise continues to begin one in Monheim with the building of a plant protection center.

Further development to today

1990 employs Bavarian of 171,000 coworkers and obtains an annual turnover of 41,643 billion DM. Bavarian dedicates itself increases to the new sales markets in Eastern Europe. Thus 1994 take up a new Bavarian work to bitter field the production of aspirin . Bavarian can since 1995 into that Arise to the USA again under the name “Bavarian”, since the enterprise with purchase of the company Sterling Winthrop reacquires also the rights of the use of a name for the USA. In den Jahren 2001 und 2003 wurde Bayer mehrmals von Alternet und Multinational Monitor zu den "The 10 Worst Corporations of 200"selected. Reasons were apart from the war crimes also the numerous environmental passing, with which particularly into Asia humans come again and again to death, as well as misleading advertisement.

buying up of Aventis CropScience

in October 2001 transfers Bavarian plant protection - section of Aventis. With a priceof 7,25 billion Euro represents this the largest buying up in the history of Bavarian. One year later, at the 1. October 2002, becomes the company Bayer CropScience AG legally independently. With 22.000 coworkers and a conversion of 6,5 billion Euro places it the numbertwo on the market of the plant protection industry.

Lipobay crisis

to 8. August 2001 withdraws Bavarian the Cholesterinsenker Lipobay up to then successful at the market because of strong side effects with death sequences of the market. The active substance Cerivastatin solved in particular in combination with other Cholesterinsenkern with thatActive substance Gemifibrozil a muscle decay (Rhabdomyolyse) out. The danger was contraindicated well-known and the combination with Gemifibrozil according to enclosing note. In the USA, where Lipobay under the name Baycol was marketed, after becoming known the first complaints are submitted briefly against Bavarian. According to the business report2004 became Bavarian in approx. 14.660 cases sues (of it 14,550 in the USA). Also conditions 18. February 2005 still 6,191 procedures (6,111 of it in the USA) were pending. Without acknowledgment of a right obligation it came up to 18. February to comparisons at a value of 1,114 millionUS Dollar. Apart from the comparisons two processes with acquietals for Bavarian were terminated.

stock exchange course in the USA

since that 24. January 2002 is acted the Bavarian share also in New York under the symbol BAY. The stock exchange course should first to 26. September 2001 take place,had to be shifted then however because of the Lipobay scandal.

restructuring 2001 - 2005

to 13. September 2001 is selected Werner Wenning to the new chairman of the board Bavarian of the company. The past chairman of the board Manfred cutter becomes a supervisory board chairman. Under the new chief executive Wenning begins one the largestPaging phases of the company between 2002 and 2005. The substantial economic difficulties strengthen the necessity for the reorientation due to the Lipobay crisis and the strongly broken in share quotation. First the past divisions become the Bavarian AG (plant protection, Pharma, polymers and chemistry) into independent partial companies (Bavarian CropScience, Bavarian HealthCare,Bavarian of polymer and Bavarian chemicals) under the roof Bavarian getting thing forms. Further parts the Bavarian AG are separated in service companies, like Bavarian Technology services, Bavarian Industry services and Bavarian Business services. Also in other countries substanzielle divisions are separated into independent societies.

At the end of of 2003it is communicated that the partial company Bavarian chemicals as well as larger parts of the plastic business of the partial company Bavarian of polymer than independent society is separated from the company. The partial company Bavarian of polymer is renamed in Bavarian of material Science. The splitting off of the ranges is to the 1. February 2005 completelyin form of a spin Offs and carried out with the stock exchange course of the company Lanxess.

In the summer 2004 announced, the OTC becomes - section (prescription-free medicines) Swiss Roche with beginning of the yearly 2005 (inclusive the 50-prozentigen of portion of the common OTC Joint venture) taken over. With this assumption the Pharma range becomesaccordingly again aligned. A goal is it now to become the enterprise in the market for prescription-free medicines, leading world-wide.

The restructuring led the Bavarian company out from the intermediate red numbers again. According to the 3. Quarter report is increased the conversion by 19 per cent on 6,5 billion EUR. Furthermore the company result of 52 millions improved EUR to 493 millions EUR strongly. The company focuses thereby for 2005 a settled PUBLIC EXHIBITION FOR MULTIMEDIA - growth for the whole year of approximately 50 per cent.

in March 2006

that gave assumption plans to Schering AGBavarian company an assumption offer for the citizen of Berlin Pharmahersteller Schering AG off. Together with the Bavarian HealthCare - section Diagnostika and Pharma would come the new Pharmasparte on a gross income of approx. 14.7 billion Euro and would rank that among world-wide 12 largest enterprises of the industry. The new enterprise“Bavarian Schering Pharma “is to be called and the past Schering head office in Berlin maintained.

development of the numbers of employees

list of the Bavarian works

(chronological after structure)

• Wuppertal - Barmen (1863)
• Krefeld - Uerdingen (1877)
• Wuppertal - Elberfeld (1878)
• Leverkusen (1895 -1912)
• Dormagen (1917)
• Antwerp (1967)
• Brunsbüttel (1973)
• Monheim (1979)
• bitter field (1992)

literature

• gentleman man, Hans Erwin; Xhonneux, Pascal; Groth, Silke; „Integrated value management at the Bavarian AG “in „Controlling “number 8/9, August/September 1999, S.399 - 406

Web on the left of

• homepage the Bavarian AG
• article over Bavarian AG with knowmore.org
• homepage of the partial company Bavarian MaterialScience AG
• homepage of the partial company Bavarian CropScience AG
• homepage of the partial company Bavarian HealthCare AG
• homepage the Bavarian Industry services GmbH & cost. OHG
• homepagethe Bavarian Business services GmbH
• homepage the Bavarian Technology services GmbH
• CBG Coordination against Bavarian dangers registered association. (Critical shareholders)
• Telepolis text: Bavarian image campaign vs. Kinderarbeit in India

enterprise in the German share index

Adidas Salomon | Alliance | Altana | BASF | Bavarian | BMW | Commerzbank | Continental | DaimlerChrysler | Deutsche Bank | German stock exchange | German Lufthansa | German post office | German Telekom | E.ON | Fresenius Medical Care | Handle | Hypo material Estate | Infineon | Lime tree | MAN ONE | Metro | Munich back | RWE | SAP | Schering | Siemens | ThyssenKrupp | TUI | Volkswagen